Bromocriptine in the treatment of post-polio fatigue: a pilot study with implications for the pathophysiology of fatigue.

@article{Bruno1996BromocriptineIT,
  title={Bromocriptine in the treatment of post-polio fatigue: a pilot study with implications for the pathophysiology of fatigue.},
  author={Richard Bruno and Julianne R. Zimmerman and S J Creange and Todd Lewis and T Molzen and N M Frick},
  journal={American journal of physical medicine & rehabilitation},
  year={1996},
  volume={75 5},
  pages={340-7}
}
Fatigue is the most commonly reported and most disabling of all post-polio sequelae (PPS). Bromocriptine mesylate (Parlodel) was employed in a placebo-controlled trial in five survivors of paralytic polio who continued to report moderate to severe daily fatigue after complying with the conservative treatments prescribed for PPS. Placebo was given for 4 wk… CONTINUE READING